95399-71-6,MFCD00865781
Catalog No.:AA01CB99

95399-71-6 | L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
in stock  
$278.00   $195.00
- +
10mg
95%
in stock  
$500.00   $350.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01CB99
Chemical Name:
L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
CAS Number:
95399-71-6
Molecular Formula:
C23H34NO5P
Molecular Weight:
435.4935
MDL Number:
MFCD00865781
SMILES:
O=C(N1C[C@@H](C[C@H]1C(=O)O)C1CCCCC1)CP(=O)(CCCCc1ccccc1)O
Properties
Computed Properties
 
Complexity:
627  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
9  
XLogP3:
3.8  

Literature

Title: Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.

Journal: Analytical and bioanalytical chemistry 20051001

Title: Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.

Journal: Journal of chromatography. A 20050923

Title: Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats.

Journal: Journal of hypertension 20011001

Title: Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.

Journal: Hypertension (Dallas, Tex. : 1979) 20010801

Title: Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.

Journal: Journal of cardiovascular pharmacology 19891101

Title: Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.

Journal: Journal of medicinal chemistry 19880601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:95399-71-6 Molecular Formula|95399-71-6 MDL|95399-71-6 SMILES|95399-71-6 L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
Catalog No.: AA01CB99
95399-71-6,MFCD00865781
95399-71-6 | L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
Pack Size: 5mg
Purity: 95%
in stock
$278.00 $195.00
Pack Size: 10mg
Purity: 95%
in stock
$500.00 $350.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01CB99
Chemical Name: L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
CAS Number: 95399-71-6
Molecular Formula: C23H34NO5P
Molecular Weight: 435.4935
MDL Number: MFCD00865781
SMILES: O=C(N1C[C@@H](C[C@H]1C(=O)O)C1CCCCC1)CP(=O)(CCCCc1ccccc1)O
Properties
Complexity: 627  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Heavy Atom Count: 30  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 9  
XLogP3: 3.8  
Literature fold

Title: Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.

Journal: Analytical and bioanalytical chemistry20051001

Title: Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.

Journal: Journal of chromatography. A20050923

Title: Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats.

Journal: Journal of hypertension20011001

Title: Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.

Journal: Hypertension (Dallas, Tex. : 1979)20010801

Title: Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.

Journal: Journal of cardiovascular pharmacology19891101

Title: Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.

Journal: Journal of medicinal chemistry19880601

Building Blocks More >
50630-19-8
50630-19-8
Pregna-1,4-diene-3,20-dione,17-(acetyloxy)-6,9-difluoro-11,21-dihydroxy-16-methyl-, (6a,11b,16b)-
AA01CBCD
1446089-82-2
1446089-82-2
N-Desmethyl-N-benzyl Sildenafil
AA01CBGF | MFCD19705088
82414-35-5
82414-35-5
Acetamide, N-[3-[[4-(acetylamino)butyl]amino]propyl]-
AA01CBJG | MFCD08458488
71771-91-0
71771-91-0
3-Pyrrolidinemethanol, 1-methyl-2-(3-pyridinyl)-, (2R,3R)-rel-
AA01CBN3
97151-02-5
97151-02-5
Benzeneethanol,b-[[4-[2-(dimethylamino)ethoxy]phenyl]phenylmethylene]-a-methyl-,(bE)-
AA01CBQ6 | MFCD02101152
60696-39-1
60696-39-1
Benzene-2,3,6-d3-acetic-a,a-d2 acid, 4,5-dihydroxy-
AA01CBTN | MFCD00209710
2088449-88-9
2088449-88-9
Isopropyl 5-(Diphenylphosphoryl)pentanoate
AA01CBWC
950912-80-8
950912-80-8
PF-670462
AA01CC00 | MFCD12828759
1217675-13-2
1217675-13-2
Lubiprostone-d7
AA01CC36
55814-41-0
55814-41-0
Benzamide, 2-methyl-N-[3-(1-methylethoxy)phenyl]-
AA01CC68 | MFCD00144739
Submit
© 2017 AA BLOCKS, INC. All rights reserved.